[ad_1] Merck’s multiple sclerosis drug evobrutinib didn’t meet a key goal in late-stage trials. The German pharmaceutical company’s phase 3 clinical trials for the drug did not achieve their primary…
Tag: XE:MRK
Microchips in the Parmigiano and Other Ways Europeans Are Fighting Fake Food
[ad_1] Parmesan producers are among those seeking ways to their protect billion-dollar markets. [ad_2] Source link
Companies Try New Strategy to Stay in China: Siloing
[ad_1] As tensions rise between Washington and Beijing, firms are seeking ways to wall off China businesses in case relations worsen. [ad_2] Source link
Drugmakers Raise Prices on Nearly 1,000 Medicines but Show Restraint
[ad_1] Health List prices climb by 5.6% on average as new federal law aims to lower drug costs [ad_2] Source link